Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2006; 12(12): 1849-1858
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1849
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1849
Adjuvant radiochemotherapy n (%) | Neoadjuvant radiochemotherapy n (%) | All n (%) | |
Anemia before RT | |||
No | 78 (47.6) | 14 (50.0) | 92 (47.9) |
Yes | 86 (52.4) | 14(50.0) | 100 (52.1) |
Anemia after RT | |||
No | 102 (62.2) | 8 (28.6) | 110 (57.3) |
Yes | 62 (37.8) | 20 (71.4) | 82 (42.7) |
Hemoglobin during RT | |||
Hb increase | 106 (64.6) | 10 (35.7) | 116 (60.4) |
Hb decrease | 58 (35.4) | 18 (64.3) | 76 (39.6) |
- Citation: Weissenberger C, Geissler M, Otto F, Barke A, Henne K, Plehn GV, Rein A, Müller C, Bartelt S, Henke M. Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: The Freiburg experience (1989-2002). World J Gastroenterol 2006; 12(12): 1849-1858
- URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1849.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i12.1849